Aterosclerose assintomática em síndrome de sjogren primária
Ano de defesa: | 2016 |
---|---|
Autor(a) principal: | |
Orientador(a): | |
Banca de defesa: | |
Tipo de documento: | Dissertação |
Tipo de acesso: | Acesso aberto |
Idioma: | por |
Instituição de defesa: |
Universidade Federal de São Paulo (UNIFESP)
|
Programa de Pós-Graduação: |
Não Informado pela instituição
|
Departamento: |
Não Informado pela instituição
|
País: |
Não Informado pela instituição
|
Palavras-chave em Português: | |
Link de acesso: | https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=4460398 http://repositorio.unifesp.br/handle/11600/46282 |
Resumo: | Objectives: To evaluate subclinical atherosclerosis in patients with Sjögren syndrome using non-invasive methods.Patients and methods: We assessed traditional risk factors such as hypertension, diabetes, dyslipidemia, smoking and family history of atherosclerosis. Patients with prior cardiovascular events and a history of atherosclerosis were excluded. Clinical and laboratory features were recorded, as well as the EULAR Sjogren?s Syndrome Activity Index (ESSDAI) calculation. The atherosclerosis evaluation was done by carotid intima-media thickness (CIMT), measured by ultrasonography, and ankle brachial index (ABI).Results: Fifteen patients (31%) had at least one traditiona risk factor and 65.3% had an ESSDAI score from mild to moderate. Only two patients had increased CIMT. However, 60% presented ABI alterations. The Multiple Correspondence Analysis (MCA) showed a clear correlation between low ABI and the positivity of autoantibodies (ANA, anti-SSA, RF). Conclusions: The subgroup of patients with positive autoantibodies is at a higher risk of early atherosclerosis, which indicates the need for more careful monitoring in this group. |